This Practice-Changing Gene Test Could Tell Doctors Which Patients With Breast Cancer Can Skip Chemo

New clinical trial research suggests a gene test can identify breast cancer patients who can safely skip chemotherapy. Avoiding chemo spares patients from debilitating side effects like brain fog, nausea, and nerve damage. This innovation promises to personalize treatment and improve quality of life for survivors.